Recommendations for the management of urinary disorders in multiple sclerosis: a consensus of the Italian Multiple Sclerosis Study Group
Valentina Zipoli(University of Florence), Angelo Ghezzi, Alessandra Protti(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Francesca Sperli(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Antonio Bertolotto(Neuroscience Institute), E. Montanari(University of Milan), Giulio Del Popolo(Azienda Ospedaliero-Universitaria Careggi), C. Scandellari(Gonzaga University), Sarah Rasia(Vita-Salute San Raffaele University), Andrea Salonia(Vita-Salute San Raffaele University), Antonio Uccelli(Istituti di Ricovero e Cura a Carattere Scientifico), Maria Pia Amato(University of Florence), M. Comola(Vita-Salute San Raffaele University), Maria Laura Lopes de Carvalho(Associazione Italiana Sclerosi Multipla), Paolo Di Benedetto(University of Udine), Francesco Patti(University of Catania), Roberto Carone(Azienda Ospedaliero-Universitaria Careggi), Ubaldo Del Carro(Vita-Salute San Raffaele University), M. Spinelli, Claudio Solaro(Rina Services (Italy)), Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla), Antonella Giannantoni(University of Perugia)
Cited by 48
Related Papers
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
|Multiple Sclerosis Journal|2018|706
Multiple sclerosis progression: time for a new mechanism-driven framework
|The Lancet Neurology|2022|624
European Association of Urology Guidelines on Male Sexual and Reproductive Health: 2021 Update on Male Infertility
|European Urology|2021|612
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)
|The Lancet|2002|552
Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis
|The Lancet Neurology|2015|523